Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Substance P receptor blocker, aprepitant, inhibited cutaneous and other neurogenic inflammation side effects of the EGFR1-TKI, erlotinib.
Journal: Molecular and cellular biochemistry
Published: September 24, 2019
Mg-supplementation attenuated lipogenic and oxidative/nitrosative gene expression caused by Combination Antiretroviral Therapy (cART) in HIV-1-transgenic rats.
Journal: PloS one
Published: October 12, 2018
Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: August 21, 2018
Combination ART-Induced Oxidative/Nitrosative Stress, Neurogenic Inflammation and Cardiac Dysfunction in HIV-1 Transgenic (Tg) Rats: Protection by Mg.
Journal: International journal of molecular sciences
Published: June 28, 2018
EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.
Journal: Journal of cardiovascular pharmacology
Published: October 25, 2014
Mg supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress, and cardiac dysfunction in rats.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology
Published: September 20, 2013
Hypomagnesemia-related inflammation in heart disease and diabetes
Journal: Cirugia y cirujanos
Published: February 19, 2013
Genomic profiling reveals the potential role of TCL1A and MDR1 deficiency in chemotherapy-induced cardiotoxicity.
Journal: International journal of biological sciences
Published: February 09, 2013
Angiotensin II promotes iron accumulation and depresses PGI₂ and NO synthesis in endothelial cells: effects of losartan and propranolol analogs.
Journal: Canadian journal of physiology and pharmacology
Published: October 17, 2012
d-Propranolol protects against oxidative stress and progressive cardiac dysfunction in iron overloaded rats.
Journal: Canadian journal of physiology and pharmacology
Published: August 24, 2012
The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction.
The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction.
Journal: Canadian journal of physiology and pharmacology
Published: June 01, 2012
Hypomagnesemia and inflammation: clinical and basic aspects.
Journal: Annual review of nutrition
Published: March 13, 2012
Last Updated: 09/26/2026